{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:33:13Z","timestamp":1772515993750,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["03201215060D"],"award-info":[{"award-number":["03201215060D"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lfs.2019.05.057","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T10:22:47Z","timestamp":1559384567000},"page":"116501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination"],"prefix":"10.1016","volume":"232","author":[{"given":"Yuejuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-1660","authenticated-orcid":false,"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.05.057_bb0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2019.05.057_bb0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.05.057_bb0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1750-3639.2009.00271.x","article-title":"Cerebellar cortical demyelination in the murine cuprizone model","volume":"20","author":"Skripuletz","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0030","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1039\/b701896g","article-title":"Unravelling the chemical nature of copper cuprizone","author":"Messori","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.lfs.2019.05.057_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(99)00181-1","article-title":"The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro","volume":"168","author":"Cammer","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2019.05.057_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","article-title":"The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia","volume":"32","author":"Pasquini","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2019.05.057_bb0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.018","article-title":"Mobilization of circulating endothelial progenitor cells by dl-3-n-butylphthalide in acute ischemic stroke patients","volume":"25","author":"Zhao","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.lfs.2019.05.057_bb0050","first-page":"93","article-title":"[Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats]. Zhongguo yi xue ke xue yuan xue bao","volume":"24","author":"Dong","year":"2002","journal-title":"Acta Acad. Med. Sinicae"},{"key":"10.1016\/j.lfs.2019.05.057_bb0055","first-page":"796","article-title":"Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats","volume":"24","author":"Chang","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2019.05.057_bb0060","first-page":"433","article-title":"Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats","volume":"21","author":"Xu","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2019.05.057_bb0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/cns.12681","article-title":"N-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"23","author":"Zhou","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2019.05.057_bb0070","first-page":"1760","article-title":"Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"125","author":"Feng","year":"2012","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2019.05.057_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clineuro.2015.06.024","article-title":"Dl-3-n-butylphthalide is effective for demyelination: a case-combined study","volume":"137","author":"Wu","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.lfs.2019.05.057_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.05.057_bb0085","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2019.05.057_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2015.10.024","article-title":"Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model","volume":"38","author":"Wang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.lfs.2019.05.057_bb0100","doi-asserted-by":"crossref","first-page":"408927","DOI":"10.1155\/2015\/408927","article-title":"Mitochondria-targeted protective compounds in Parkinson's and Alzheimer's diseases","volume":"2015","author":"Fernandez-Moriano","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2019.05.057_bb0105","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2011.03.007","article-title":"Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease","volume":"33","author":"Xiong","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.lfs.2019.05.057_bb0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuropharm.2011.10.009","article-title":"DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis","volume":"62","author":"Feng","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2019.05.057_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/156720212801618956","article-title":"DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment","volume":"9","author":"Zhang","year":"2012","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.lfs.2019.05.057_bb0120","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3892\/etm.2016.3139","article-title":"Efficacy and safety comparison of DL-3-n-butylphthalide and cerebrolysin: effects on neurological and behavioral outcomes in acute ischemic stroke","volume":"11","author":"Xue","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2019.05.057_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2019.05.057_bb0130","first-page":"1733","article-title":"L-3-n-butylphthalide protects against vascular dementia via activation of the Akt kinase pathway","volume":"8","author":"Huai","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.lfs.2019.05.057_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1352458509353649","article-title":"MRI of the corpus callosum in multiple sclerosis: association with disability","volume":"16","author":"Ozturk","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.lfs.2019.05.057_bb0140","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/brain\/awq359","article-title":"IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system","volume":"134","author":"Raasch","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2019.05.057_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000350139","article-title":"3-N-butylphthalide (NBP) attenuates the amyloid-beta-induced inflammatory responses in cultured astrocytes via the nuclear factor-kappaB signaling pathway","volume":"32","author":"Wang","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2019.05.057_bb0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","article-title":"Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination","volume":"124","author":"Bruck","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0155","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2019.05.057_bb0160","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","article-title":"Programmed cell death in animal development and disease","volume":"147","author":"Fuchs","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.05.057_bb0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/dvdy.20124","article-title":"Activation of apoptosis and caspase-3 in zebrafish early gastrulae","volume":"231","author":"Negron","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.lfs.2019.05.057_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/mcne.1998.0715","article-title":"Gene expression in brain during cuprizone-induced demyelination and remyelination","volume":"12","author":"Morell","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2019.05.057_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2990.2007.00879.x","article-title":"Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination","volume":"34","author":"Lindner","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519304138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519304138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:29:09Z","timestamp":1758400149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519304138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"alternative-id":["S0024320519304138"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.05.057","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116501"}}